A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus ...
Oct 21, 2023
0
0
(Medical Xpress)—Men are almost three times more likely to get oesophageal cancer than women – one of the biggest gender gaps in cancer rates – according to figures released from Cancer Research UK.
Jun 18, 2013
0
0
Results of a new European Academy of Dermatology and Venereology (EADV) survey presented today at EADV's Spring Symposium show that 1.71% of the adult European general population reported having skin cancer, meaning some ...
May 12, 2022
1
3
(HealthDay) -- Basal cell carcinoma (BCC) on the ear is significantly more likely to be aggressive, and occurs more frequently in men, according to a study published in the May issue of the Journal of the American Academy ...
Apr 18, 2012
0
0
(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat patients with locally advanced basal cell carcinoma that has returned despite surgery or radiation, or who are not candidates ...
Jul 25, 2015
0
14
Mount Sinai researchers have discovered a previously unknown mechanism in which not-yet-malignant cells from early breast cancer tumors travel to other organs and, eventually, "turn on" and become metastatic breast cancer.
Apr 26, 2022
0
71
An enzyme that plays an active role in inflammation could be a natural way to suppress tumors and ulcers in the colon that are found in colitis associated cancer (CAC), a type of colorectal cancer that is driven by chronic ...
Jan 3, 2017
0
87
Compared to chimpanzees, our closest evolutionary cousins, humans are particularly prone to developing advanced carcinomas—the type of tumors that include prostate, breast, lung and colorectal cancers—even in the absence ...
Dec 9, 2020
0
42
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern ...
Sep 22, 2023
0
59
(HealthDay)—Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older, the U.S. Food and Drug Administration announced yesterday.
Jun 18, 2019
0
4
